Treatment of severe forms of alcoholic hepatitis: Where are we going?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 1, 2008, Pages

  Mathurin, Philippe ^a,b   Louvet, Alexandre ^a,b   Dharancy, Sébastien ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Alcoholic hepatitis; Corticosteroids; Lille model

Indexed keywords

ALCOHOL; CORTICOSTEROID; INFLIXIMAB; PENTOXIFYLLINE; PREDNISOLONE; TUMOR NECROSIS FACTOR;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DEATH; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL; TREATMENT INDICATION;

EID: 40749099045     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.05286.x     Document Type: Conference Paper

References (17)

1. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978 75 : 193 9.
2. Stewart SF, Day CP. The management of alcoholic liver disease. J. Hepatol. 2003 38 : S12 S13.
3. Carithers RL Jr, Herlong HF, Diehl AM et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial. Ann. Intern. Med. 1989 110 : 685 90.
4. Phillips M, Curtis H, Portmann B, Donaldson N, Bomford A, O'Grady J. Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis - a randomised clinical trial. J. Hepatol. 2006 44 : 784 90.
5. Ramond MJ, Poynard T, Rueff B et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N. Engl. J. Med. 1992 326 : 507 12.
6. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am. J. Gastroenterol. 1998 93 : 2022 36.
7. Christensen E, Gludd C. Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995 37 : 113 8.
8. Mathurin P, Mendenhall C, Carithers RL et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials. J. Hepatol. 2002 36 : 480 7.
9. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000 119 : 1637 48.
10. Mathurin P, Abdelnour M, Ramond MJ et al. Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone. Hepatology 2003 38 : 1363 9.
11. Louvet A, Naveau S, Abdelnour M et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007 45 : 1348 54.
12. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995 21 : 1304 9.
13. Yin M, Wheeler MD, Kono H et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 1999 117 : 942 50.
14. Naveau S, Chollet-Martin S, Dharancy S et al. A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004 39 : 1390 7.
15. Spahr L, Rubbia-Brandt L, Pugin J et al. Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood. J. Hepatol. 2001 35 : 582 9.
16. Tsukamoto H. Animal models of alcoholic liver injury. Clin. Liver Dis. 1998 2 : 739 52.
17. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA 1997 94 : 1441 5.